Multi-modal magnetic resonance imaging quantifies atherosclerosis and vascular dysfunction in patients with type 2 diabetes mellitus.

Vascular magnetic resonance imaging (MRI) is emerging as a powerful research tool. We studied 18 patients with type 2 diabetes mellitus and 20 controls (all with coronary artery disease). MRI measured distensibility, pulse wave velocity (PWV) and atherosclerosis in the aorta, and brachial artery flo...

Full description

Bibliographic Details
Main Authors: Lee, J, Shirodaria, C, Jackson, C, Robson, M, Antoniades, C, Francis, J, Wiesmann, F, Channon, K, Neubauer, S, Choudhury, R
Format: Journal article
Language:English
Published: 2007
_version_ 1797059339083579392
author Lee, J
Shirodaria, C
Jackson, C
Robson, M
Antoniades, C
Francis, J
Wiesmann, F
Channon, K
Neubauer, S
Choudhury, R
author_facet Lee, J
Shirodaria, C
Jackson, C
Robson, M
Antoniades, C
Francis, J
Wiesmann, F
Channon, K
Neubauer, S
Choudhury, R
author_sort Lee, J
collection OXFORD
description Vascular magnetic resonance imaging (MRI) is emerging as a powerful research tool. We studied 18 patients with type 2 diabetes mellitus and 20 controls (all with coronary artery disease). MRI measured distensibility, pulse wave velocity (PWV) and atherosclerosis in the aorta, and brachial artery flow-mediated dilatation (FMD). Patients with diabetes showed lower aortic distensibility (2.1 x 10(-3) vs . 3.5 x 10(-3) mmHg-1, p<0.01), faster PWV (8.8 vs ., 6.2 m/s, p<0.01) and impaired FMD (8.5% vs . 13.8%, p<0.05). Diabetes was an independent negative predictor of distensibility. Aortic atherosclerosis was similar in the two groups. There was a negative correlation between aortic distensibility and atherosclerosis in control subjects only, suggesting that other factors such as protein cross-linking may explain lower aortic distensibility in diabetes. MRI provides comprehensive vascular phenotyping in patients with type 2 diabetes and is likely to be useful in studies of disease progression and drug therapy.
first_indexed 2024-03-06T20:02:48Z
format Journal article
id oxford-uuid:27e522cf-6313-473c-86f9-d2ec058cdfff
institution University of Oxford
language English
last_indexed 2024-03-06T20:02:48Z
publishDate 2007
record_format dspace
spelling oxford-uuid:27e522cf-6313-473c-86f9-d2ec058cdfff2022-03-26T12:09:33ZMulti-modal magnetic resonance imaging quantifies atherosclerosis and vascular dysfunction in patients with type 2 diabetes mellitus.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:27e522cf-6313-473c-86f9-d2ec058cdfffEnglishSymplectic Elements at Oxford2007Lee, JShirodaria, CJackson, CRobson, MAntoniades, CFrancis, JWiesmann, FChannon, KNeubauer, SChoudhury, RVascular magnetic resonance imaging (MRI) is emerging as a powerful research tool. We studied 18 patients with type 2 diabetes mellitus and 20 controls (all with coronary artery disease). MRI measured distensibility, pulse wave velocity (PWV) and atherosclerosis in the aorta, and brachial artery flow-mediated dilatation (FMD). Patients with diabetes showed lower aortic distensibility (2.1 x 10(-3) vs . 3.5 x 10(-3) mmHg-1, p<0.01), faster PWV (8.8 vs ., 6.2 m/s, p<0.01) and impaired FMD (8.5% vs . 13.8%, p<0.05). Diabetes was an independent negative predictor of distensibility. Aortic atherosclerosis was similar in the two groups. There was a negative correlation between aortic distensibility and atherosclerosis in control subjects only, suggesting that other factors such as protein cross-linking may explain lower aortic distensibility in diabetes. MRI provides comprehensive vascular phenotyping in patients with type 2 diabetes and is likely to be useful in studies of disease progression and drug therapy.
spellingShingle Lee, J
Shirodaria, C
Jackson, C
Robson, M
Antoniades, C
Francis, J
Wiesmann, F
Channon, K
Neubauer, S
Choudhury, R
Multi-modal magnetic resonance imaging quantifies atherosclerosis and vascular dysfunction in patients with type 2 diabetes mellitus.
title Multi-modal magnetic resonance imaging quantifies atherosclerosis and vascular dysfunction in patients with type 2 diabetes mellitus.
title_full Multi-modal magnetic resonance imaging quantifies atherosclerosis and vascular dysfunction in patients with type 2 diabetes mellitus.
title_fullStr Multi-modal magnetic resonance imaging quantifies atherosclerosis and vascular dysfunction in patients with type 2 diabetes mellitus.
title_full_unstemmed Multi-modal magnetic resonance imaging quantifies atherosclerosis and vascular dysfunction in patients with type 2 diabetes mellitus.
title_short Multi-modal magnetic resonance imaging quantifies atherosclerosis and vascular dysfunction in patients with type 2 diabetes mellitus.
title_sort multi modal magnetic resonance imaging quantifies atherosclerosis and vascular dysfunction in patients with type 2 diabetes mellitus
work_keys_str_mv AT leej multimodalmagneticresonanceimagingquantifiesatherosclerosisandvasculardysfunctioninpatientswithtype2diabetesmellitus
AT shirodariac multimodalmagneticresonanceimagingquantifiesatherosclerosisandvasculardysfunctioninpatientswithtype2diabetesmellitus
AT jacksonc multimodalmagneticresonanceimagingquantifiesatherosclerosisandvasculardysfunctioninpatientswithtype2diabetesmellitus
AT robsonm multimodalmagneticresonanceimagingquantifiesatherosclerosisandvasculardysfunctioninpatientswithtype2diabetesmellitus
AT antoniadesc multimodalmagneticresonanceimagingquantifiesatherosclerosisandvasculardysfunctioninpatientswithtype2diabetesmellitus
AT francisj multimodalmagneticresonanceimagingquantifiesatherosclerosisandvasculardysfunctioninpatientswithtype2diabetesmellitus
AT wiesmannf multimodalmagneticresonanceimagingquantifiesatherosclerosisandvasculardysfunctioninpatientswithtype2diabetesmellitus
AT channonk multimodalmagneticresonanceimagingquantifiesatherosclerosisandvasculardysfunctioninpatientswithtype2diabetesmellitus
AT neubauers multimodalmagneticresonanceimagingquantifiesatherosclerosisandvasculardysfunctioninpatientswithtype2diabetesmellitus
AT choudhuryr multimodalmagneticresonanceimagingquantifiesatherosclerosisandvasculardysfunctioninpatientswithtype2diabetesmellitus